Chapter/Section Purchase

1 Study Coverage
1.1 Metabotropic Glutamate Receptor 5 Product Introduction
1.2 Market by Type
1.2.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Alloswitch-1
1.2.3 BMS-952048
1.2.4 BMS-955829
1.2.5 Dipraglurant ER
1.2.6 Others
1.3 Market by Application
1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Alcohol Addiction
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 5 Sales Estimates and Forecasts 2017-2028
2.2 Global Metabotropic Glutamate Receptor 5 Revenue Estimates and Forecasts 2017-2028
2.3 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Metabotropic Glutamate Receptor 5 Sales by Region
2.4.1 Global Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022)
2.4.2 Global Sales Metabotropic Glutamate Receptor 5 by Region (2023-2028)
2.5 Global Metabotropic Glutamate Receptor 5 Revenue by Region
2.5.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers
3.1.1 Global Top Metabotropic Glutamate Receptor 5 Manufacturers by Sales (2017-2022)
3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metabotropic Glutamate Receptor 5 in 2021
3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers
3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2017-2022)
3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 5 Revenue in 2021
3.3 Global Metabotropic Glutamate Receptor 5 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Metabotropic Glutamate Receptor 5 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metabotropic Glutamate Receptor 5 Sales by Type
4.1.1 Global Metabotropic Glutamate Receptor 5 Historical Sales by Type (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 5 Forecasted Sales by Type (2023-2028)
4.1.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
4.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type
4.2.1 Global Metabotropic Glutamate Receptor 5 Historical Revenue by Type (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 5 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
4.3 Global Metabotropic Glutamate Receptor 5 Price by Type
4.3.1 Global Metabotropic Glutamate Receptor 5 Price by Type (2017-2022)
4.3.2 Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 5 Sales by Application
5.1.1 Global Metabotropic Glutamate Receptor 5 Historical Sales by Application (2017-2022)
5.1.2 Global Metabotropic Glutamate Receptor 5 Forecasted Sales by Application (2023-2028)
5.1.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
5.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application
5.2.1 Global Metabotropic Glutamate Receptor 5 Historical Revenue by Application (2017-2022)
5.2.2 Global Metabotropic Glutamate Receptor 5 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
5.3 Global Metabotropic Glutamate Receptor 5 Price by Application
5.3.1 Global Metabotropic Glutamate Receptor 5 Price by Application (2017-2022)
5.3.2 Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Metabotropic Glutamate Receptor 5 Market Size by Type
6.1.1 North America Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
6.1.2 North America Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
6.2 North America Metabotropic Glutamate Receptor 5 Market Size by Application
6.2.1 North America Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
6.2.2 North America Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
6.3 North America Metabotropic Glutamate Receptor 5 Market Size by Country
6.3.1 North America Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
6.3.2 North America Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 5 Market Size by Type
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
7.2 Europe Metabotropic Glutamate Receptor 5 Market Size by Application
7.2.1 Europe Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
7.2.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
7.3 Europe Metabotropic Glutamate Receptor 5 Market Size by Country
7.3.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
7.3.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Type
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
8.2 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Application
8.2.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
8.2.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
8.3 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Region
8.3.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2017-2028)
8.3.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 5 Market Size by Type
9.1.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
9.1.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
9.2 Latin America Metabotropic Glutamate Receptor 5 Market Size by Application
9.2.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
9.2.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
9.3 Latin America Metabotropic Glutamate Receptor 5 Market Size by Country
9.3.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
9.3.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Type
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
10.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Application
10.2.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
10.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country
10.3.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Overview
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Addex Therapeutics Ltd Recent Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Corporation Information
11.2.2 Aevi Genomic Medicine Inc Overview
11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aevi Genomic Medicine Inc Recent Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Overview
11.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Company Recent Developments
11.4 Eisai Co Ltd
11.4.1 Eisai Co Ltd Corporation Information
11.4.2 Eisai Co Ltd Overview
11.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eisai Co Ltd Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Heptares Therapeutics Ltd
11.6.1 Heptares Therapeutics Ltd Corporation Information
11.6.2 Heptares Therapeutics Ltd Overview
11.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heptares Therapeutics Ltd Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Merz Pharma GmbH & Co KgaA
11.8.1 Merz Pharma GmbH & Co KgaA Corporation Information
11.8.2 Merz Pharma GmbH & Co KgaA Overview
11.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merz Pharma GmbH & Co KgaA Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Overview
11.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis AG Recent Developments
11.10 Richter Gedeon Nyrt
11.10.1 Richter Gedeon Nyrt Corporation Information
11.10.2 Richter Gedeon Nyrt Overview
11.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Richter Gedeon Nyrt Recent Developments
11.11 Sumitomo Dainippon Pharma Co Ltd
11.11.1 Sumitomo Dainippon Pharma Co Ltd Corporation Information
11.11.2 Sumitomo Dainippon Pharma Co Ltd Overview
11.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
11.12 Toray Industries Inc
11.12.1 Toray Industries Inc Corporation Information
11.12.2 Toray Industries Inc Overview
11.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Toray Industries Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Metabotropic Glutamate Receptor 5 Industry Chain Analysis
12.2 Metabotropic Glutamate Receptor 5 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metabotropic Glutamate Receptor 5 Production Mode & Process
12.4 Metabotropic Glutamate Receptor 5 Sales and Marketing
12.4.1 Metabotropic Glutamate Receptor 5 Sales Channels
12.4.2 Metabotropic Glutamate Receptor 5 Distributors
12.5 Metabotropic Glutamate Receptor 5 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Metabotropic Glutamate Receptor 5 Industry Trends
13.2 Metabotropic Glutamate Receptor 5 Market Drivers
13.3 Metabotropic Glutamate Receptor 5 Market Challenges
13.4 Metabotropic Glutamate Receptor 5 Market Restraints
14 Key Findings in The Global Metabotropic Glutamate Receptor 5 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer